Michael P. Mazanetz

1.0k total citations
16 papers, 802 citations indexed

About

Michael P. Mazanetz is a scholar working on Molecular Biology, Computational Theory and Mathematics and Materials Chemistry. According to data from OpenAlex, Michael P. Mazanetz has authored 16 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Computational Theory and Mathematics and 4 papers in Materials Chemistry. Recurrent topics in Michael P. Mazanetz's work include Computational Drug Discovery Methods (10 papers), Protein Structure and Dynamics (7 papers) and Enzyme Structure and Function (4 papers). Michael P. Mazanetz is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Protein Structure and Dynamics (7 papers) and Enzyme Structure and Function (4 papers). Michael P. Mazanetz collaborates with scholars based in United Kingdom, Germany and China. Michael P. Mazanetz's co-authors include Peter M. Fischer, Osamu Ichihara, Richard Law, Yuri Alexeev, Dmitri G. Fedorov, Mark Whittaker, Iñaki Morao, Charles A. Laughton, Julien Michel and Michelle Southey and has published in prestigious journals such as The Journal of Physical Chemistry B, Nature Reviews Drug Discovery and Physical Chemistry Chemical Physics.

In The Last Decade

Michael P. Mazanetz

16 papers receiving 788 citations

Peers

Countries citing papers authored by Michael P. Mazanetz

Since Specialization

Citations

This map shows the geographic impact of Michael P. Mazanetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Mazanetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Mazanetz more than expected).

Fields of papers citing papers by Michael P. Mazanetz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Mazanetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Mazanetz. The network helps show where Michael P. Mazanetz may publish in the future.

Co-authorship network of co-authors of Michael P. Mazanetz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Mazanetz. A scholar is included among the top collaborators of Michael P. Mazanetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Mazanetz. Michael P. Mazanetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma 2020 ·Bioorganic & Medicinal Chemistry Letters ·John Porter, Yao Ding, Sarah Hale, (unknown), Angela Byun Robinson, Michael P. Mazanetz, Yubo Wu, Yinping Ma, Kelly Conlon, (unknown)	6
2	Ligand- and Structure-Based Drug Design and Optimization using KNIME 2019 ·Current Medicinal Chemistry ·Michael P. Mazanetz, (unknown), Ewa I. Chudyk	13
3	Assessment of Hydration Thermodynamics at Protein Interfaces with Grid Cell Theory 2016 ·The Journal of Physical Chemistry B ·(unknown), Michelle Southey, Michael P. Mazanetz, Alexander Heifetz, Michael J. Bodkin, Richard Law, Richard H. Henchman, Julien Michel	13
4	Evaluation of water displacement energetics in protein binding sites with grid cell theory 2015 ·Physical Chemistry Chemical Physics ·(unknown), Michelle Southey, Michael P. Mazanetz, (unknown), Michael J. Bodkin, Richard Law, Julien Michel	24
5	Evaluation of Host–Guest Binding Thermodynamics of Model Cavities with Grid Cell Theory 2014 ·Journal of Chemical Theory and Computation ·Julien Michel, Richard H. Henchman, (unknown), Michelle Southey, Michael P. Mazanetz, Richard Law	21
6	Investigation of the Flexibility of Protein Kinases Implicated in the Pathology of Alzheimer’s Disease 2014 ·Molecules ·Michael P. Mazanetz, Charles A. Laughton, Peter M. Fischer	11
7	Drug Discovery Applications for KNIME: An Open Source Data Mining Platform 2013 ·Current Topics in Medicinal Chemistry ·Michael P. Mazanetz, (unknown), (unknown), Iñaki Morao	8
8	GAMESS As a Free Quantum-Mechanical Platform for Drug Research 2013 ·Current Topics in Medicinal Chemistry ·Yuri Alexeev, Michael P. Mazanetz, Osamu Ichihara, Dmitri G. Fedorov	7
9	GAMESS As a Free Quantum-Mechanical Platform for Drug Research 2012 ·Current Topics in Medicinal Chemistry ·Yuri Alexeev, Michael P. Mazanetz, Osamu Ichihara, Dmitri G. Fedorov	116
10	Drug Discovery Applications for KNIME: An Open Source Data Mining Platform 2012 ·Current Topics in Medicinal Chemistry ·Michael P. Mazanetz, (unknown), (unknown), Iñaki Morao	80
11	Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method 2011 ·Journal of Cheminformatics ·Michael P. Mazanetz, Osamu Ichihara, Richard Law, Mark Whittaker	96
12	Using Electrophysiology and In Silico Three-Dimensional Modeling to Reduce Human Ether-à-go-go Related Gene K ⁺ Channel Inhibition in a Histamine H3 Receptor Antagonist Program 2010 ·Assay and Drug Development Technologies ·Adam J. Davenport, Clemens Möller, Alexander Heifetz, Michael P. Mazanetz, Richard Law, Andreas Ebneth, Mark J. Gemkow	12
13	A Study of CDK2 Inhibitors Using a Novel 3D‐QSAR Method Exploiting Receptor Flexibility 2009 ·QSAR & Combinatorial Science ·Michael P. Mazanetz, (unknown), Charles A. Laughton, Peter M. Fischer	6
14	Exploiting glycogen synthase kinase 3β flexibility in molecular recognition 2008 ·Biochemical Society Transactions ·Michael P. Mazanetz, (unknown), Charles A. Laughton, Peter M. Fischer	6
15	Active Site Pressurization: A New Tool for Structure-Guided Drug Design and Other Studies of Protein Flexibility 2008 ·Journal of Chemical Information and Modeling ·(unknown), Michael P. Mazanetz, Hao Wang, Peter M. Fischer, Charles A. Laughton	17
16	Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases 2007 ·Nature Reviews Drug Discovery ·Michael P. Mazanetz, Peter M. Fischer	366

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact